DiaMedica Therapeutics (DMAC) EPS (Basic) (2018 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly EPS (Basic) came in at -$0.19 in Q1 2026, down 3.78% year-on-year from -$0.19 in Q1 2025, and down 130.73% quarter-over-quarter from -$0.08 in Q4 2025.
DiaMedica Therapeutics (DMAC) EPS (Basic) (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' EPS (Basic) history runs 9 years deep, the most recent figure standing at -$0.19 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 3.78% year-over-year to -$0.19 in Q1 2026; TTM through Mar 2026 was -$0.56, a 11.03% increase from a year earlier, with the FY2025 full-year figure at -$0.59, up 2.09% from the prior year.
- EPS (Basic) eased to -$0.19 in Q1 2026 per DMAC's latest filing, from -$0.08 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.08 in Q4 2025 and bottomed at -$0.2 in Q1 2023.
- The 5-year median for EPS (Basic) is -$0.15 (2024), against an average of -$0.15.
- Across the five-year window, EPS (Basic) sank 50.25% in 2023 and soared 58.62% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.14 in 2022, then decreased by 11.72% to -$0.16 in 2023, then retreated by 23.38% to -$0.2 in 2024, then surged by 58.62% to -$0.08 in 2025, then tumbled by 130.73% to -$0.19 in 2026.
- Per Business Quant, the three latest DMAC EPS (Basic) figures stand at -$0.19 (Q1 2026), -$0.08 (Q4 2025), and -$0.17 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | DiaMedica Therapeutics | 364.72 Mn | 364.72 Mn | - | -0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.19 |
| Dec 31, 2025 | -0.08 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -0.18 |
| Mar 31, 2025 | -0.18 |
| Dec 31, 2024 | -0.20 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | -0.13 |
| Mar 31, 2024 | -0.14 |
| Dec 31, 2023 | -0.16 |
| Sep 30, 2023 | -0.12 |
| Jun 30, 2023 | -0.16 |
| Mar 31, 2023 | -0.20 |
| Dec 31, 2022 | -0.14 |
| Sep 30, 2022 | -0.12 |
| Jun 30, 2022 | -0.13 |
| Mar 31, 2022 | -0.13 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | -0.18 |
| Jun 30, 2021 | -0.17 |